Description
Tesamorelin, CJC-1295 (no DAC), and Ipamorelin is a research peptide blend formulated to investigate growth hormone axis modulation through combined GHRH and ghrelin receptor pathways. Tesamorelin and CJC-1295 (Mod GRF 1–29) activate GHRH receptor signaling via cAMP/PKA cascades, while Ipamorelin targets the GHS-R1a receptor, promoting calcium mobilization. This blend is used in endocrine and receptor biology studies exploring synergistic GH pulsatility and hypothalamic–pituitary coordination.
For research use only. Not for human consumption.
References:
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Frohman LA et al., Front Neuroendocrinol, 2002 23(3):257–291
Kojima M et al., Nature, 1999 402(6762):656–660
Reviews
There are no reviews yet.